Our Treatment Principles and Results in Malignant Melanoma

Volume: 28 Number: 1 March 1, 2002
  • Güzin Yeşim Özgenel
  • Ramazan Kahveci
  • Mesut Özcan
  • Selçuk Akın
  • Serhat Özbek
  • Gülaydan Filiz
EN TR

Our Treatment Principles and Results in Malignant Melanoma

Abstract

In this study, our experiences with 30 cases who were treated for melanoma between the years 1993-2001 in the Department of Plastic and Reconstructive Surgery of Uludağ University Medical School were presented. These cases were evaluated according to the age, sex, localization, histologic type and level, nodal status and recurrence. Eighteen cases were men and 12 cases were women. The mean age was 61 years. Histologic examinations revealed that 17 cases were nodular, 6 cases were superficial, 4 cases were acral lentiginous and 3 cases were lentigo melanoma. According to the Clark's level, 43.3% of the cases were classified in level IV-V, 13.3% in level III and 43.3% in level II. At the admission, 53.3% of the cases were found to have regional lymph node metastasis. Local recurrence was seen in 10% of the cases at different time points following the operation. We excised the lesions with 3-cm free margin including the fascia. Regional lymph node dissection was performed in cases who had regional lymph node metastatis. In cases who had no lymph node metastasis, sentinel lymph node biopsy was performed.

Keywords

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Güzin Yeşim Özgenel This is me

Ramazan Kahveci This is me

Mesut Özcan This is me

Selçuk Akın This is me

Serhat Özbek This is me

Gülaydan Filiz This is me

Publication Date

March 1, 2002

Submission Date

March 1, 2002

Acceptance Date

-

Published in Issue

Year 2002 Volume: 28 Number: 1

APA
Özgenel, G. Y., Kahveci, R., Özcan, M., Akın, S., Özbek, S., & Filiz, G. (2002). Our Treatment Principles and Results in Malignant Melanoma. Journal of Uludağ University Medical Faculty, 28(1), 13-16. https://izlik.org/JA74EX27LP
AMA
1.Özgenel GY, Kahveci R, Özcan M, Akın S, Özbek S, Filiz G. Our Treatment Principles and Results in Malignant Melanoma. Journal of Uludağ University Medical Faculty. 2002;28(1):13-16. https://izlik.org/JA74EX27LP
Chicago
Özgenel, Güzin Yeşim, Ramazan Kahveci, Mesut Özcan, Selçuk Akın, Serhat Özbek, and Gülaydan Filiz. 2002. “Our Treatment Principles and Results in Malignant Melanoma”. Journal of Uludağ University Medical Faculty 28 (1): 13-16. https://izlik.org/JA74EX27LP.
EndNote
Özgenel GY, Kahveci R, Özcan M, Akın S, Özbek S, Filiz G (March 1, 2002) Our Treatment Principles and Results in Malignant Melanoma. Journal of Uludağ University Medical Faculty 28 1 13–16.
IEEE
[1]G. Y. Özgenel, R. Kahveci, M. Özcan, S. Akın, S. Özbek, and G. Filiz, “Our Treatment Principles and Results in Malignant Melanoma”, Journal of Uludağ University Medical Faculty, vol. 28, no. 1, pp. 13–16, Mar. 2002, [Online]. Available: https://izlik.org/JA74EX27LP
ISNAD
Özgenel, Güzin Yeşim - Kahveci, Ramazan - Özcan, Mesut - Akın, Selçuk - Özbek, Serhat - Filiz, Gülaydan. “Our Treatment Principles and Results in Malignant Melanoma”. Journal of Uludağ University Medical Faculty 28/1 (March 1, 2002): 13-16. https://izlik.org/JA74EX27LP.
JAMA
1.Özgenel GY, Kahveci R, Özcan M, Akın S, Özbek S, Filiz G. Our Treatment Principles and Results in Malignant Melanoma. Journal of Uludağ University Medical Faculty. 2002;28:13–16.
MLA
Özgenel, Güzin Yeşim, et al. “Our Treatment Principles and Results in Malignant Melanoma”. Journal of Uludağ University Medical Faculty, vol. 28, no. 1, Mar. 2002, pp. 13-16, https://izlik.org/JA74EX27LP.
Vancouver
1.Güzin Yeşim Özgenel, Ramazan Kahveci, Mesut Özcan, Selçuk Akın, Serhat Özbek, Gülaydan Filiz. Our Treatment Principles and Results in Malignant Melanoma. Journal of Uludağ University Medical Faculty [Internet]. 2002 Mar. 1;28(1):13-6. Available from: https://izlik.org/JA74EX27LP

ISSN: 1300-414X, e-ISSN: 2645-9027

Creative Commons License
Journal of Uludag University Medical Faculty is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
2023